(Q36269772)

English

Cost-effectiveness of recombinant versus urinary follicle-stimulating hormone in assisted reproduction techniques in the Spanish public health care system

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Cost-effectiveness of recombinant versus urinary follicle-stimulating hormone in assisted reproduction techniques in the Spanish public health care system (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

0 references

author name string

Alberto Romeu

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Juan Balasch

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

José A Ruiz Balda

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Pedro N Barri

4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Salim Daya

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Jean P Auray

6

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Gerald Duru

7

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Ariel Beresniak

8

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

José A Peinado

9

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

publication date

1 August 2003

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Journal of Assisted Reproduction and Genetics

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

20

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

8

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

294-300

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Human follicle-stimulating hormone produced by recombinant DNA technology: a review for clinicians

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455272

30 September 2017

Economic modelling before clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455272

30 September 2017

Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455272

30 September 2017

Reflections on the cost-effectiveness of recombinant FSH in assisted reproduction. The clinician's perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455272

30 September 2017

Induction of ovulation in women undergoing assisted reproductive techniques: recombinant human FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin HP).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455272

30 September 2017

Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women undergoing ovarian stimulation after pituitary suppression for in vitro fertilization: implications fo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455272

30 September 2017

An introduction to Markov modelling for economic evaluation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455272

30 September 2017

Superovulation before IVF by recombinant versus urinary human FSH (combined with a long GnRH analog protocol): A comparative study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455272

30 September 2017

Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455272

29 June 2018

A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F) with highly purified urinary FSH (Metrodin) HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455272

22 September 2018

A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455272

22 September 2018

Pharmaco-economic aspects of in-vitro fertilization in Italy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12948090

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of the cost effectiveness of recombinant versus urinary follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection programs in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/12948090

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/12948090

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization. Recombinant Human FSH Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12948090

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction

1 reference

https://pubmed.ncbi.nlm.nih.gov/12948090

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1024899806149

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36269772&oldid=2198510460"